Turn this list into an evaluation

Each entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.

Prepare with a buyer guide:

Clinical guide links appear when this list contains a current reviewed example. They do not classify or endorse the other entries. All buyer guides · Compare exact records · Documented families

FDA-cleared K260316

CMN Capillary Function with Oncology Virtual Expert

Cercare Medical A/S

Authorized purpose: Cercare Neurosuite with Capillary Function and Oncology Virtual Expert processes CT or MR information to provide perfusion, tissue-blood-volume, diffusion, labeling, and quantification support for adult brain glioma workflows.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Brain
Decision
2026-06-22
FDA-cleared K252947

HistoSonics® Planning Tool

HistoSonics, Inc.

Authorized purpose: HistoSonics Planning Tool is a stand-alone visualization and comparison tool for CT and MR studies used to plan histotripsy target localization, treatment volume, acoustic path, and patient position.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Liver; kidneys; lungs; ribs; and skin
Decision
2026-05-29
FDA-cleared K252190

DeepBT Detector-Plus

Aitewan Biomedical Technology, Inc.

Authorized purpose: DeepBT Detector-Plus provides initial gross-tumor-volume contours on T1-weighted contrast-enhanced and optional T2-weighted MR images for radiation-treatment planning in adults with the labeled brain tumors.

Modality
Radiotherapy Planning Imaging
Anatomy
Brain tumors, including metastases, meningiomas, and acoustic neuromas
Decision
2026-04-10
FDA-cleared K252992

CT Rembra RT; CT Areta RT; CT Rembra

Philips Healthcare (Suzhou) Co., Ltd.

Authorized purpose: CT Rembra RT, CT Areta RT, and CT Rembra support whole-body diagnostic imaging, oncology, radiotherapy planning, interventional, vascular, neurological, cardiovascular, and qualified lung-screening workflows for all ages.

Modality
CT/CTA
Anatomy
Multi-region
Decision
2026-03-23
FDA-cleared K252304

syngo.via RT Image Suite VC10

Varian Medical Systems, Inc.

Authorized purpose: syngo.via RT Image Suite VC10 provides three-dimensional and four-dimensional multimodality visualization, registration, fusion, contouring, and planning support for radiation-treatment preparation.

Modality
Radiotherapy Planning Imaging
Anatomy
Brain, pelvis, thorax, abdomen, targets, organs at risk, and moving tumors or organs
Decision
2026-03-18
FDA-cleared K252261

InferCare RECIST

Beijing Infervision Healthcare Medical Technology Co., Ltd.

Authorized purpose: InferCare RECIST is a post-processing application for longitudinal medical-image display, lesion measurement, registration, tracking, segmentation, three-dimensional reconstruction, and RECIST reporting by trained professionals.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Tumors and lesions in adult patients age 21 and older
Decision
2026-03-13
FDA-cleared K253413

LiverMultiScan (v6.0)

Perspectum, Ltd.

Authorized purpose: LiverMultiScan v6.0 is MR diagnostic software for non-invasive liver-health assessment that generates, displays, and supports review of MR data and quantitative cT1, PDFF, and LIC metrics or composite images for trained healthcare-professional interpretation.

Modality
MRI
Anatomy
Liver
Decision
2026-03-09
FDA-cleared K253535

Ligence Heart

Ligence Uab

Ligence Heart is a fully automated software platform that processes, analyses and makes measurements on acquired transthoracic cardiac ultrasound images, automatically producing a full report with measurements of several key cardiac structural and functional parameters. The data produced by this software is intended to be used to support qualified cardiologists or sonographers for clinical decision making. Ligence Heart is indicated for use in adult patients. Ligence Heart has not been validated for the assessment of congenital heart disease, valve disease, pericardial disease, and/or intra-cardiac lesions (e.g., tumors, thrombi). Limitations: Poor image capture will lead to poor annotations and subsequent measurements. Multiple image quality algorithms are used to filter out images of poor quality. Our software complements good patient care and does not exempt the user from the responsibility to provide supervision, clinically review the patient, and make appropriate clinical decisions. If no gender is present, female referenced guideline values will be used for conclusions. If Body Surface Area (BSA) is not present, indexed values cannot be provided. During image acquisition, inappropriate use of the echo machine, use of non-cardiac ultrasound probes, or use of suboptimal settings (e.g., gain, contrast, depth) may lead to lower accuracy of the software. Ligence Heart has not been validated in patients with prosthetic or surgically altered cardiac valves, implantable intracardiac devices, or irregular (non-sinus) rhythm; these conditions may affect automated measurement accuracy.

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2026-02-27
FDA-authorized DEN250007

Delivery Date AI

Ultrasound AI

Authorized purpose: Delivery Date AI analyzes obstetric ultrasound images to provide a predicted delivery date for singleton pregnancies in women age 18 or older at 14 0/7 through 36 6/7 weeks when the last-menstrual-period date or first-trimester ultrasound is unreliable or unavailable; the output is an aid to clinical judgment.

Modality
Ultrasound
Anatomy
Pregnancy and obstetric anatomy
Decision
2026-02-11
FDA-cleared K254016

MI View&GO

Siemens Medical Solutions USA, Inc.

Authorized purpose: MI View&GO is a medical diagnostic application for viewing, manipulating, quantifying, analyzing, and comparing PET, nuclear-medicine, CT, and MR images across one or more time points, including labeled oncology, cardiology, neurology, organ-function, and radiotherapy-planning workflows.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Whole body, organs, tumors, heart, brain, and oncology regions
Decision
2026-02-10
FDA-cleared K252188

EMLA (Elekta Evo); EMLA (VersaHD); EMLA (Elekta Harmony Pro); EMLA (Elekta Infintiy); EMLA (Elekta Harmony); EMLA (Elekta Synergy)

Elekta Solutions AB

Authorized purpose: The EMLA family delivers external-beam radiation therapy for adult and pediatric patients with benign, malignant, or metastatic disease. Authorized techniques vary by model: Synergy and Harmony include conventional and fractionated delivery; Infinity and Harmony Pro add SBRT/SABR; Versa HD and Evo also support SRS and specified functional disorders.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2026-01-15
FDA-cleared K252970

BriefCase-Triage: CARE Multi-triage CT Body

Aidoc Medical, Ltd.

Authorized purpose: Adult contrast-enhanced and non-contrast CT triage for 11 chest, abdominal, and pelvic findings: diverticulitis, abdominal-pelvic abscess, appendicitis, intestinal ischemia/pneumatosis, obstructive renal stone, small- and large-bowel obstruction, spleen injury, liver injury, kidney injury, and pelvic fracture.

Modality
CT/CTA
Anatomy
Chest, Abdomen, and Pelvis
Decision
2026-01-07
FDA-cleared K252029

AI-CVD

HeartLung Corporation

Authorized purpose: AI-CVD provides automated quantitative CT-derived anatomical and density measurements for clinician review, including calcium scores, cardiac and vascular measurements, lung and liver density, bone mineral density, and muscle/fat composition; it is opportunistic decision support, not diagnostic interpretation or risk prediction.

Modality
CT/CTA
Anatomy
Chest, abdomen, heart, lungs, liver, aorta, pulmonary artery, bone, muscle, and fat
Decision
2025-12-19
FDA-cleared K252922

Neosoma Brain Mets

Neosoma, Inc.

Authorized purpose: Neosoma Brain Mets semi-automatically segments and contours previously diagnosed brain metastases on T1 post-contrast brain MRI to support radiation-oncology treatment planning.

Modality
MRI
Anatomy
Brain; previously diagnosed brain metastases
Decision
2025-12-17
FDA-cleared K251931

BioTraceIO Vision (V1.7)

Techsomed Medical Technologies

Authorized purpose: BioTraceIO Vision V1.7 processes CT and MR images to support ablation target and needle planning and zone confirmation for the labeled liver and kidney workflows.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Liver; kidney; and ablation target anatomy
Decision
2025-09-08
FDA-cleared K251839

uMI Panvivo (uMI Panvivo); uMI Panvivo (uMI Panvivo S)

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMI Panvivo and Panvivo S acquire and display PET and CT information for anatomical and functional imaging, radiopharmaceutical distribution, and the labeled oncology, cardiology, neurology, infection, inflammation, radiotherapy-planning, and interventional workflows.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body; brain; head and neck; heart; lung; breast; gastrointestinal; urinary; genital; and musculoskeletal anatomy
Decision
2025-07-17
FDA-cleared K251766

TumorSight Viz

SimBioSys, Inc.

Authorized purpose: TumorSight Viz processes dynamic contrast-enhanced breast MRI for patients with biopsy-proven early-stage or locally advanced breast cancer, providing registration, subtraction, segmentation, 3D renderings, measurements, kinetic curves, parametric maps, MIPs, and reformats for physician visualization and analysis; results are not the sole basis for patient management.

Modality
MRI
Anatomy
Breast
Decision
2025-07-08
FDA-cleared K251528

syngo.via MI Workflows; Scenium; syngo MBF

Siemens Medical Solutions USA, Inc.

Authorized purpose: syngo.via MI Workflows, Scenium, and syngo MBF provide PET, SPECT, nuclear-medicine, CT, and MR viewing, manipulation, quantification, longitudinal comparison, and analysis for oncology, cardiology, neurology, organ function, and selected radiation-planning support.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2025-07-03
FDA-cleared K243863

Opulus™ Lymphoma Precision

Roche Molecular Systems, Inc.

Authorized purpose: Opulus Lymphoma Precision segments and visualizes lesions and measures total metabolic tumor volume in whole-body FDG-PET/CT for patients already diagnosed with FDG-avid lymphoma; trained physicians can accept/reject annotated output, but radiologist review makes the final interpretation and the device is not a screening/diagnostic substitute.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole-body FDG-PET/CT
Decision
2025-05-30
FDA-cleared K250427

TAIMedImg DeepMets

Taiwan Medical Imaging Co., Ltd.

Authorized purpose: TAIMedImg DeepMets assists trained professionals by providing initial gross-tumor-volume contours on axial contrast-enhanced T1 brain MR images for radiation-treatment planning in adults with known brain metastases; the contours require thorough review and are not a replacement for manual contouring.

Modality
Radiotherapy Planning Imaging
Anatomy
Brain metastases in adults
Decision
2025-05-28
FDA-cleared K242624

Medical Image Post-processing Software (uOmnispace.CT)

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uOmnispace.CT provides healthcare institutions with tools to view, manipulate, evaluate, and analyze medical CT images, including colon, lung, vessel, brain, cardiac, liver, rib, spine, dual-energy, perfusion, and cardiovascular applications described in the exact FDA submission.

Modality
CT/CTA
Anatomy
Colon, lungs and airway, vessels, brain, heart, liver, ribs, spine, and other CT regions
Decision
2025-05-14
FDA-cleared K240398

RayStation 2023B, RayPlan 2023B, RayStation 2024A, RayPlan 2024A, RayStation 2024A SP3, RayPlan 2024A SP3

RaySearch Laboratories AB (PUBL)

Authorized purpose: RayStation and RayPlan releases covered by K240398 are configurable radiotherapy and medical-oncology software that proposes or supports treatment plans from user inputs, with authorized users required to review and approve plans before treatment.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2025-04-04
FDA-cleared K242822

ART-Plan+ (v.3.0.0)

Therapanacea SAS

Authorized purpose: ART-Plan assists trained radiation-therapy professionals with multimodal image review, registration, contouring, and the release-specific planning functions described in K242822. This release included Annotate and TumorBox contouring plus SmartPlan automatic prostate-plan generation for import into the treatment-planning system for dose calculation, review, and approval.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2025-02-25
FDA-cleared K242994

OncoStudio (OS-01)

OncoSoft. Co., Ltd.

Authorized purpose: OncoStudio OS-01 creates initial deep-learning organs-at-risk contours from CT images of the head and neck, thorax, abdomen, and pelvis for radiation-oncology review, editing, and DICOM RT export.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2025-02-24
FDA-cleared K242825

Prenuvo Body Composition

Prenuvo

Authorized purpose: Prenuvo Body Composition is software that non-invasively quantifies fat, muscle, and organs from compatible MR DICOM datasets and displays internal body information, including liver and body-composition measurements, for adults age 18 and older.

Modality
MRI
Anatomy
Whole-body anatomy, liver, organs, fat, and muscle
Decision
2025-01-17
FDA-cleared K243538

uMI Panvivo (uMI Panvivo); uMI Panvivo (uMI Panvivo S)

Shanghai United Imaging Healthcare Co.,Ltd.

Authorized purpose: The uMI Panvivo PET/CT system provides anatomical and functional images. PET depicts the distribution of approved radiopharmaceuticals and CT provides diagnostic tomographic and photon-attenuation information. The FDA indication describes qualified-professional use for detection, localization, evaluation, diagnosis, staging, restaging, monitoring, and follow-up in oncology, infection and inflammation, neurology, and other labeled workflows, plus radiotherapy planning, interventional radiology, and protocol-constrained low-dose lung-cancer screening.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body and regional anatomy represented in PET/CT studies
Decision
2024-12-12
FDA-cleared K241543

DrAid™ for Liver Segmentation

VinBrain Joint Stock Company

Authorized purpose: Support trained professionals in visualizing, evaluating, measuring, and reporting liver and physician-identified liver lesions on multiphase CT; it does not generate diagnoses or potential findings directly.

Modality
CT/CTA
Anatomy
Liver and physician-identified liver lesions.
Decision
2024-12-06
FDA-cleared K243189

TumorSight Viz

SimBioSys, Inc.

Authorized purpose: Visualize and analyze DCE breast MRI studies for patients with biopsy-proven early-stage or locally advanced breast cancer, including processing, measurements, and configurable finding visualization; results are not a sole basis for patient management.

Modality
MRI
Anatomy
Breast, including biopsy-proven breast tumors/findings.
Decision
2024-10-25
FDA-cleared K241280

Constellation (CON-001)

Q Bio, Inc.

Authorized purpose: Constellation is intended for non-invasive labeling and calculation of quantitative measurements for anatomical regions using whole-body DICOM MR images gathered on a GE MR450W. It is intended for healthy adult patients and may be used as a clinical decision-support tool, but not in triage events, emergency medicine, or critical care; a clinician retains responsibility for diagnosis.

Modality
MRI
Anatomy
Whole body including lower-limb muscles, visceral and subcutaneous adipose tissue, kidneys, liver, spleen, lungs, and brain structures
Decision
2024-09-12
FDA-cleared K233977

Velacur

Sonic Incytes

Authorized purpose: Velacur Sonic measures liver tissue stiffness, ultrasound attenuation, and volume density fat fraction with shear-wave and ultrasound measurements to aid clinical management of liver disease, including steatosis, within the labeled workflow.

Modality
Ultrasound
Anatomy
Liver
Decision
2024-09-04
FDA-cleared K242300

MI View&GO

Siemens Medical Solutions USA, Inc.

Authorized purpose: MI View&GO is a medical diagnostic application for viewing, manipulating, quantifying, analyzing, and comparing PET, nuclear-medicine, CT, and MR images. The FDA material describes use across labeled oncology, cardiology, neurology, organ-function, and radiotherapy-planning workflows.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Multi-region PET, nuclear-medicine, CT, and MR studies
Decision
2024-08-30
FDA-cleared K233209

uOmnispace.CT

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uOmnispace.CT is software for viewing, manipulating, evaluating, and analyzing medical images within healthcare institutions. The FDA indication lists colon visualization, dental panoramic and paraxial reconstruction, lung and airway segmentation and quantitative parameters, nodule analysis, vessel and brain-perfusion analysis, heart and coronary analysis, calcium scoring, dynamic analysis, bone-structure labeling, liver evaluation, dual-energy processing, and cardiovascular combined analysis.

Modality
CT/CTA
Anatomy
Colon, jaw, lungs, airways, brain, heart, vessels, liver, spine, ribs, and other labeled CT regions
Decision
2024-05-17
FDA-cleared K232928

DeepContour (V1.0)

Wisdom Technologies., Inc.

Authorized purpose: DeepContour uses deep-learning CT processing to generate editable organ contours and RTSTRUCT objects for selected adult radiation-treatment planning workflows, with quantitative statistics, registration, and three-dimensional visualization; it does not contour tumors.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2024-05-07
FDA-cleared K232799

syngo.via RT Image Suite

Siemens Medical Solutions USA, Inc.

syngo.via RT Image Suite VB80 supports trained radiation-oncology professionals with multimodality visualization, registration, advanced contouring, treatment preparation, Synthetic CT, dose evaluation, and DICOM export.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2024-04-26
FDA-cleared K240773

VisAble.IO

Techsomed

Authorized purpose: VisAble.IO is CT and MR image-processing software for liver-ablation procedures. It imports images from CT and MR scanners and facility PACS systems, assists physicians with ablation-target identification and virtual ablation-needle placement, and assists confirmation of ablation zones.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Liver, hepatic and portal veins, ablation targets, and ablation zones
Decision
2024-04-15
FDA-cleared K231690

iCAS-LV

HighRAD Ltd.

Authorized purpose: Support trained physicians in visualizing and evaluating physician-identified liver lesions on multi-phase reconstructed CT, including lesion size, shape, position, and change over time; not for standalone diagnosis or patient-management decisions.

Modality
CT/CTA
Anatomy
Liver (physician-identified liver lesions)
Decision
2024-03-01
FDA-cleared K233030

BoneMRI

MRIguidance B.V

MRI-processing software that creates an added bone-contrast image series for review beside the original scan.

Modality
MRI
Anatomy
Spine
Decision
2024-03-01
FDA-cleared K231855

QOCA® image Smart RT Contouring System

Quanta Computer Inc.

Authorized purpose: QOCA image Smart RT Contouring System automatically contours DICOM CT imaging data using deep-learning algorithms. Generated contours may be used as input to external-beam radiation-therapy planning and are output as RTSTRUCT objects for radiation-oncology departments.

Modality
Radiotherapy Planning Imaging
Anatomy
Adult patient anatomy represented in CT images and radiation-treatment structures
Decision
2024-02-13
FDA-cleared K233080

HealthFLD

Nano-X AI Ltd.

Authorized purpose: Provide quantitative and qualitative liver analysis and mean attenuation measurement to support clinician evaluation and assessment of fatty liver in patients aged 18-75 whose CT includes a significant part of the liver; not for diagnosis or risk assessment of fatty liver disease.

Modality
CT/CTA
Anatomy
Liver
Decision
2024-02-08
FDA-cleared K233677

Biograph VK10

Siemens Medical Solutions USA, Inc.

Authorized purpose: The Biograph VK10 combines X-ray CT and PET to register and fuse anatomic and physiologic information, supports independent CT or PET imaging, and aids trained professionals in detecting, localizing, diagnosing, staging, and restaging disease, lesions, tumors, and organ function; the CT may also support radiotherapy planning, interventional procedures, and low-dose lung-cancer screening in high-risk populations.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body, cardiovascular, neurological, oncologic, and organ-function imaging
Decision
2024-01-12
FDA-cleared K231130

TumorSight Viz

SimBioSys, Inc.

Authorized purpose: TumorSight Viz analyzes dynamic contrast-enhanced breast MRI for visualization and analysis of biopsy-proven early-stage or locally advanced breast cancer, including registration, subtraction, measurements, and three-dimensional views to support physician review.

Modality
MRI
Anatomy
Breast; early-stage or locally advanced breast cancer
Decision
2023-12-26
FDA-cleared K233176

uOmnispace.MI

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uOmnispace.MI is software for viewing, processing, evaluating, and analyzing PET, CT, MR, and SPECT images within healthcare institutions, with labeled applications for multimodality reporting, follow-up registration and lesion segmentation, dynamic PET analysis and time-activity curves, brain PET relative-activity analysis, and cardiac short-axis, perfusion, activity, and function analysis.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Multi-region PET, CT, MR, and SPECT examinations including oncology, neurology, cardiology, brain, and cardiac analyses
Decision
2023-12-20
FDA-cleared K232000

syngo.via MI Workflows; Scenium; syngo MBF

Siemens Medical Solutions USA, Inc.

Authorized purpose: syngo.via MI Workflows VB80A, Scenium VE60, and syngo MBF VB30 support PET, SPECT, nuclear-medicine, CT, and MR viewing, quantification, analysis, longitudinal comparison, organ segmentation, tumor-burden assessment, tau analysis, myocardial blood-flow analysis, and selected radiotherapy-planning support.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2023-11-28
FDA-cleared K232145

ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System

Siemens Medical Solutions USA, Inc.

Authorized purpose: The ACUSON Sequoia and Sequoia Select systems provide ultrasound images or signals for the labeled fetal, abdominal, pediatric, neonatal cephalic, small-parts, OB/GYN, cardiac, pelvic, vascular, adult-cephalic, musculoskeletal, and peripheral-vascular applications; the system also supports UDFF liver-fat-fraction measurement and the ACUSON Origin includes intracardiac and intraluminal imaging guidance during adult and pediatric cardiac procedures.

Modality
Ultrasound
Anatomy
Fetal, abdominal, pediatric, neonatal cephalic, small parts, OB/GYN, cardiac, pelvic, vascular, adult cephalic, musculoskeletal, peripheral vascular, intracardiac, and intraluminal cardiac or great-vessel anatomy
Decision
2023-10-30
FDA-cleared K232045

MeVis Liver Suite

MeVis Medical Solutions AG

Authorized purpose: CT and MRI image analysis, segmentation, visualization, and volumetry for adult abdominal treatment planning and follow-up, including liver surgery, living-donor, transplant, and oncologic workflows; it is not a diagnostic viewer or PACS replacement.

Modality
CT/CTA
Anatomy
Liver
Decision
2023-10-27
FDA-cleared K232712

uMI Panorama

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMI Panorama combines PET and CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and fused PET/CT images for qualified healthcare professionals supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation across oncology, cardiology, neurology, and other disorders; its CT subsystem can also perform standalone diagnostic imaging and protocol-governed low-dose lung cancer screening.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2023-10-03
FDA-cleared K231928

EFAI RTSUITE CT HCAP-Segmentation System

Ever Fortune.AI Co., Ltd.

Authorized purpose: EFAI HCAPSeg assists trained radiation-oncology professionals with radiation-treatment planning by providing initial deep-learning contours of organs at risk on non-contrast CT images for transfer to a DICOM-compliant treatment-planning system.

Modality
Radiotherapy Planning Imaging
Anatomy
Adult organs at risk on non-contrast CT during radiation-treatment planning
Decision
2023-09-25
FDA-cleared K223639

VisAble.IO

TechsoMed

Authorized purpose: VisAble.IO is a CT image-processing software package for liver-ablation procedures that imports CT images from CT scanners and facility PACS, assists physicians in identifying ablation targets and planning virtual ablation-needle placement, and assists in confirming ablation zones.

Modality
CT/CTA
Anatomy
Liver and ablation targets
Decision
2023-08-28
FDA-cleared K231572

uMI Panorama

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMI Panorama GS combines 148 cm axial-field-of-view PET with CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and registered or fused PET/CT images supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation in oncology, cardiology, neurology, inflammation, infection, and other disorders. The CT subsystem can also perform standalone diagnostic imaging and protocol-governed low-dose lung cancer screening.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2023-07-26
FDA-cleared K231833

Biograph Vision.X and Biograph Vision.X Edge

Siemens Medical Solutions USA, Inc.

Authorized purpose: The Biograph Vision.X and Biograph Vision.X Edge combine X-ray CT and PET to register and fuse anatomic and physiologic information, support independent CT or PET imaging, aid trained professionals in detecting, localizing, diagnosing, staging, and restaging disease, lesions, tumors, and organ function, and support radiotherapy planning, interventional procedures, and low-dose lung-cancer screening in high-risk populations.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body, cardiovascular, neurological, oncologic, and organ-function imaging
Decision
2023-07-13
FDA-cleared K231459

HepaFatSmart (V2.0.0)

Resonance Health Analysis Services Pty Ltd

Authorized purpose: Provide quantitative volumetric liver fat fraction, proton-density fat fraction, and steatosis grading to support clinical diagnosis and subsequent management decisions for confirmed or suspected fatty liver disease or metabolic syndromes and to aid living-donor liver-transplant assessment and screening, with results interpreted by a trained physician.

Modality
MRI
Anatomy
Liver
Decision
2023-06-20
FDA-cleared K223212

Precision DL

GE Healthcare

Precision DL uses deep-learning image processing to enhance non-time-of-flight F-18 FDG PET images for clinical oncology review in adults and children.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2023-04-27
FDA-cleared K222312

RayStation 12A

RaySearch Laboratories AB (publ)

Authorized purpose: RayStation 12A is configurable software for radiation therapy and medical oncology that proposes treatment plans from user input. Authorized users may use reviewed and approved plans to support treatment administration; the system includes image handling, contouring, treatment planning and optimization, dose calculation and evaluation, machine commissioning, treatment interfaces, and machine-learning segmentation or planning functions.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2023-03-29
FDA-cleared K223325

uMI Panorama

Shanghai United Imaging Healthcare Co., Ltd.

Authorized purpose: uMI Panorama combines PET and CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and fused PET/CT images for qualified healthcare professionals supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation across oncology, cardiology, neurology, and other disorders; its CT subsystem can also perform standalone diagnostic imaging and protocol-governed low-dose lung cancer screening.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2023-03-10
FDA-cleared K221680

Xeleris V Processing and Review System

GE Healthcare

Authorized purpose: The Xeleris V Processing and Review System displays, processes, archives, prints, reports, and networks planar, SPECT, and PET nuclear-medicine data, with optional applications for DaTQUANT, lung analysis, brain analysis, coronary-flow reserve, prostate-cancer bone metastases, liver shunt and dose calculations, and monitoring of patient radiation doses from nuclear-medicine imaging data.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body, lung, brain, liver, cardiac, coronary, and other anatomy represented in labeled nuclear-medicine studies
Decision
2023-03-01
FDA-cleared K230197

BoneMRI v1.6

MRIguidance B.V.

Authorized purpose: MRI-based BoneMRI v1.6 image enhancement for visualizing pelvic and L3-S1 lumbar bone structures with enhanced contrast; not for tumor diagnosis or monitoring and not a CT replacement.

Modality
MRI
Anatomy
Spine
Decision
2023-02-22
FDA-cleared K221762

BoneMRI v1.4

MRlguidance B.V.

MRI image-enhancement software that increases bone contrast in dedicated pelvic and lower-spine examinations for professional review.

Modality
MRI
Anatomy
Pelvic sacrum, hip bones, femoral heads, and lumbar spine L3-S1
Decision
2022-11-16
FDA-cleared K220408

AVIEW RT ACS

Coreline Soft Co.,Ltd

Authorized purpose: AVIEW RT ACS is a medical image-management and processing system for radiation-treatment planning with deep-learning auto-segmentation evidence described in the exact FDA decision material; the submission compares automated organ segmentation with a predicate using Dice similarity coefficient and 95% Hausdorff distance on CT cases.

Modality
Radiotherapy Planning Imaging
Anatomy
Organs at risk across breast, head and neck, abdomen, and pelvis CT validation cases, including lung, heart, eyes, brain, mandible, kidneys, liver, femur, and bladder
Decision
2022-11-10
FDA-cleared K213960

LiverMultiScan v5 (LMSv5)

Perspectum

Authorized purpose: LiverMultiScan v5 (LMSv5) is indicated for use as a magnetic resonance diagnostic device software application for noninvasive liver evaluation that enables the generation, display and review of 2D magnetic resonance medical image data and pixel maps for MR relaxation times.LMSv5 is designed to utilize DICOM 3.0 compliant magnetic resonance image datasets, acquired from compatible MRSystems, to display the internal structure of the abdomen including the liver. Other physical parameters derived from the images may also be produced.LMSv5 provides several tools, such as automated liver segmentation and region of interest (ROI) placements, to be used for the assessment of selected regions of an image. Quantitative assessment of selected regions includes the determination of triglyceride fat fraction in the liver (PDFF), T2*, LIC (Liver Iron Concentration) and iron corrected T1(cT1) measurements. These images and the physical parameters derived from the images, when interpreted by a trained clinician, yield information that may assist in diagnosis.

Modality
MRI
Anatomy
Liver
Decision
2022-09-06
FDA-cleared K211841

MRI Planner

Spectronic Medical AB

Authorized purpose: MRI Planner creates synthetic CT images for photon external-beam radiation planning from MRI and can generate healthy-structure contours for specified brain, head-and-neck, and pelvic workflows; it is not intended to contour tumors or clinical target volumes.

Modality
Radiotherapy Planning Imaging
Anatomy
Brain
Decision
2022-08-25
FDA-cleared K222172

MI View&GO

Siemens Medical Solutions USA, Inc.

Authorized purpose: MI View&GO is a multimodality medical-image application for viewing, manipulating, quantifying, analyzing, and comparing PET, SPECT, CT, and MR images across time points in oncology, cardiology, neurology, organ-function, and radiotherapy-planning workflows.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Whole body, organs, tumors, heart, brain, and oncology regions
Decision
2022-08-19
FDA-cleared K221727

syngo.CT Extended Functionality

Siemens Medical Solutions USA, Inc.

Authorized purpose: syngo.CT Extended Functionality provides advanced visualization and processing tools for CT-acquired or reconstructed data, including labeled vessel, spectral, pulmonary, oncology, nodule, trauma, measurement, and analysis workflows under professional review.

Modality
CT/CTA
Anatomy
Vessels, lungs, nodules, oncology, trauma, and other anatomy represented in CT studies
Decision
2022-07-13
FDA-cleared K220497

CoLumbo

Smart Soft Healthcare AD

Authorized purpose: CoLumbo is an image post-processing and measurement software tool that provides quantitative spine measurements from previously-acquired DICOM lumbar spine Magnetic Resonance (MR) images for users' review, analysis, and interpretation. It provides the following functionality to assist users in visualizing, measuring and documenting out-of range measurements:- Feature segmentation;- Feature measurement;- Threshold-based labeling of out-of-range measurement; and- Export of measurement results to a written report for user's review, revise and approval. Columbo does not produce or recommend any type of medical diagnosis or treatment. Instead, it simply helps users to more easily identify and classify features in lumbar MR images and compile a report. The user is responsible forconfirming/modifying settings, reviewing and verifying the software-generated measurements, inspecting out-of-range measurements, and approving draft report content using their medical judgment and discretion. The device is intended to be used only by hospitals and other medical institutions. Only DICOM images of MRI acquired from lumbar spine exams of patients aged 18 and above are considered to be valid input. CoLumbo does not support DICOM images of patients that are pregnant, undergo MRI scan with contrast media, or have post-operational complications, scoliosis, tumors, infections, fractures.

Modality
MRI
Anatomy
Spine
Decision
2022-06-23
FDA-cleared K213504

Aquilion ONE (TSX-306A/3) V10.12 with Spectral Imaging System, Vitrea Software Package, VSTP-001A

Canon Medical Systems Corporation

Authorized purpose: Aquilion ONE with Vitrea VSTP-001A provides whole-body CT acquisition and reconstruction with labeled FIRST, AiCE, spectral, cardiac, vascular, pulmonary, neurologic, abdominal, stone, gout, and embolization-planning applications in the associated Vitrea package.

Modality
CT/CTA
Anatomy
Whole body including head; brain, heart, lungs, liver, vessels, urinary stones, gout, and other anatomy represented in labeled CT workflows
Decision
2022-06-16
FDA-cleared K212915

MVision AI Segmentation

MVision AI

Authorized purpose: MVision AI Segmentation automatically generates initial contours from CT images for radiotherapy planning; the contours are transferred for professional visualization, review, modification, and approval, and the labeled software is not intended for lesion or tumor detection or real-time adaptive planning.

Modality
Radiotherapy Planning Imaging
Anatomy
Head and neck, brain, breast, lung and abdomen, male pelvis, and female pelvis structures
Decision
2022-05-03
FDA-cleared K220590

aPROMISE X

EXINI Diagnostics AB

Authorized purpose: aPROMISE X accepts, stores, displays, manipulates, quantifies, and reports digital medical images from nuclear-medicine imaging using PSMA PET/CT, with tools for marking regions of interest and quantitative oncology review by healthcare professionals or researchers.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole-body oncology anatomy represented in PSMA PET/CT studies
Decision
2022-04-29
FDA-cleared K214081

MRCAT Head & Neck

Philips Oy

Generation of MR-derived, CT-like density images for radiotherapy planning and patient-positioning workflows in patients with soft-tissue tumors of the head and neck.

Modality
Radiotherapy Planning Imaging
Anatomy
Head/Neck
Decision
2022-04-05
FDA-cleared K203744

Arterys MICA

Arterys Inc.

Authorized purpose: Manages, views, processes, stores, transfers, filters, manipulates, and quantitatively measures DICOM and non-DICOM images and data, with optional Cardio AI and Oncology AI support.

Modality
CT/CTA; MRI
Anatomy
Multi-region
Decision
2022-03-14
FDA-cleared K214019

syngo.CT Extended Functionality

Siemens Medical Solutions USA, Inc.

Authorized purpose: syngo.CT Extended Functionality provides advanced visualization and processing of CT-acquired or reconstructed data, with labeled trauma, spectral, vascular, pulmonary, oncology, segmentation, measurement, and analysis tools that support professional diagnosis.

Modality
CT/CTA
Anatomy
Trauma, vessels, lungs, oncology, and other anatomy represented in CT or MR studies
Decision
2022-01-20
FDA-cleared K213776

LiverSmart

Resonance Health Analysis Services Pty Ltd

Authorized purpose: Measures liver iron concentration for specified iron-overload and thalassemia/sickle-cell indications; assesses VLFF, PDFF, and steatosis grade for suspected or confirmed fatty liver disease; physician-interpreted results may support weight-loss monitoring and living-donor assessment.

Modality
MRI
Anatomy
Liver
Decision
2021-12-29
FDA-cleared K202404

BoneMRI

MRIguidance B.V

Authorized purpose: BoneMRI enhances bone contrast in pelvic MRI examinations of the sacrum, hip bones, and femoral heads; it is not intended to diagnose or monitor primary or metastatic tumors and does not replace CT.

Modality
MRI
Anatomy
Pelvic sacrum, hip bones, and femoral heads
Decision
2021-12-22
FDA-cleared K210831

OnQ Neuro

CorTechs Labs, Inc

Authorized purpose: Analyzes neurological MR images for automated segmentation, volumetric quantification, reporting, fusion, and longitudinal comparison of known pathologically confirmed brain tumors.

Modality
MRI
Anatomy
Brain; pathologically confirmed brain tumors
Decision
2021-11-19
FDA-cleared K210807

FlightPlan for Liver

GE Medical Systems SCS

Authorized purpose: Visualizes hepatic vasculature and identifies arteries near hypervascular liver lesions during planning of liver embolization.

Modality
Fluoroscopy/Angiography
Anatomy
Liver; hepatic arterial vasculature and hypervascular liver lesions
Decision
2021-10-22
FDA-cleared K211764

Vereos PET/CT

Philips Medical Systems Nederland B.V.

Authorized purpose: Vereos PET/CT detects, localizes, diagnoses, stages, restages, and follows treatment response in oncology, cardiology, and neurology and can provide diagnostic CT and radiotherapy-planning support; optional PET Adaptive Reconstruction is an AI-powered image-reconstruction function.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2021-08-06
FDA-cleared K211379

syngo.via RT Image Suite

Siemens Medical Solutions USA Inc.

syngo.via RT Image Suite VB60 supports trained radiation-oncology professionals with multimodality visualization, registration, contouring, treatment preparation, DICOM export, and AI-based brain or pelvis Synthetic CT.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2021-07-30
FDA-cleared K210791

Us2.v1

eko.ai Pte. Ltd. d/b/a Us2.ai

Authorized purpose: Us2.v1 is a fully automated software platform that processes, analyses and makes measurements on acquired transthoracic cardiac ultrasound images, automatically producing a full report with measurements of several key cardiac structural and functional parameters. The data produced by this software is intended to be used to support qualified cardiologists or licensed primary care providers for clinical decision-making. Us2.v1 is indicated for use in adult patients. Us2.v1 has not been validated for the assessment of congenital heart disease, valve disease, pericardial disease, and/or intra-cardiac lesions (e.g. tumors, thrombi). Please note the following limitations: -Poor image capture will lead to poor annotations and subsequent measurements. Multiple image quality algorithms are used to filter out images of poor quality. -Our software complements good patient care and does not exempt the user from the responsibility to provide supervision, clinically review the patient, and make appropriate clinical decisions. -If no gender is present, female referenced guideline values will be used for conclusions. -If Body surface area (BSA) is not present, indexed values cannot be provided. -During image acquisition, inappropriate use of the echo machine, use of non-cardiac ultrasound probes, use of suboptimal settings (e.g. gain, contrast, depth), or lack of electrocardiogram capture may lead to lower accuracy of the software.

Modality
Ultrasound
Anatomy
Heart/Cardiovascular
Decision
2021-07-27
FDA-cleared K210645

RayStation 10.1

RaySearch Laboratories AB (publ)

Authorized purpose: RayStation 10.1 is configurable treatment-planning software for radiation therapy and medical oncology that receives clinician-selected patient and treatment inputs, proposes treatment plans, and supports qualified review, approval, and export for compatible treatment-delivery workflows.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2021-06-29
FDA-cleared K203235

VBrain

Vysioneer Inc.

Authorized purpose: VBrain assists trained professionals in radiation-treatment planning by providing initial contours of known or diagnosed brain tumors on axial contrast-enhanced T1 brain MR images for adults with brain metastases, meningiomas, or acoustic neuromas; manual review remains required.

Modality
Radiotherapy Planning Imaging
Anatomy
Brain tumors represented on contrast-enhanced MRI
Decision
2021-03-19
FDA-cleared K203280

Hepatica v1 (Hepatica v1.0.0)

Perspectum Ltd.

Authorized purpose: Hepatica (Hepatica v1) is a post-processing medical device software that presents quantified metrics which may contribute to the assessment of a patient's liver health. Hepatica (Hepatica v1) uses image visualization and analysis tools to process DICOM 3.0 compliant magnetic resonance image datasets to produce semi-automatic segmented 3D models of the liver based on the work of Couinaud and the Brisbane 2000 terminology. For each identified Couinaud segment, volumetric data is determined and reported. Hepatica (Hepatica v1) may also report iron corrected-T1 (cT1) and PDFF calculated using the IDEAL method from multi-slice acquisitions, on a per segment basis, over the whole liver. Both metrics present numerical values of different fundamental liver tissue characteristics that can be used as measures of liver tissue health. Hepatica (Hepatica v1) provides trained clinicians with additional information to evaluate the volume and health of patient's liver on a segmental basis. It is not intended to replace the established procedures for the assessment of patient's liver health. However, information gathered through existing diagnostic tests, clinical evaluation of the patient, as well Hepatica (Hepatica v1), may support surgical decision making.

Modality
MRI
Anatomy
Liver
Decision
2021-01-12
FDA-cleared K202229

AI Metrics

AI Metrics, LLC

Authorized purpose: AI Metrics supports viewing, manipulation, communication, storage, annotation, analysis, and comparison of medical images and anatomical datasets across modalities and timepoints for workflow automation and follow-up documentation in radiology, oncology, and other medical-imaging environments.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Multimodality medical-image datasets including CT and MR
Decision
2020-12-22
FDA-cleared K201039

HepaFat-AI

Resonance Health Analysis Services Pty Ltd

Authorized purpose: HepaFat-AI assesses volumetric liver fat fraction, proton-density fat fraction, and steatosis grade in confirmed or suspected fatty-liver disease, supports monitoring of liver fat during weight loss, and may aid assessment or screening of living liver donors under trained physician interpretation.

Modality
MRI
Anatomy
Liver
Decision
2020-12-07
FDA-cleared K201195

syngo.via MI Workflows, syngo MBF

Siemens Medical Solutions USA, Inc.

Authorized purpose: syngo.via molecular-imaging workflows provide viewing, manipulation, quantification, analysis, and comparison of medical images from one or more modalities and time points, including PET or nuclear-medicine functional data and CT or MR anatomical data. The workflows support disease-management activities in oncology, cardiology, neurology, and organ function, and the images or results may aid radiotherapy treatment planning. The submission also describes Scenium neurology review and syngo MBF quantitative myocardial-blood-flow review for supported PET studies.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole-body, cardiac, neurologic, oncologic, organ-function, and radiotherapy-planning anatomy represented in PET, nuclear-medicine, CT, and MR studies
Decision
2020-11-18
FDA-cleared K202170

LiverMultiScan

Perspectum LTD

Authorized purpose: LiverMultiScan LMSv4 processes abdominal MRI, including liver images, to generate pixel maps and measurements for proton-density fat fraction, T2 star, and corrected T1, with automated liver segmentation and region-of-interest tools for trained clinician interpretation.

Modality
MRI
Anatomy
Abdomen including liver
Decision
2020-10-02
FDA-cleared K201232

Limbus Contour

Limbus AI Inc.

Limbus Contour assists trained radiation oncologists, dosimetrists, and physicists by generating anatomical contours from CT and MR images for radiation-treatment planning. The initial cleared release provided CT and MR automatic contouring on Windows and macOS, used file-system DICOM import and RT Structure Set export, and excluded tumor and tumor-CTV automatic contouring.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2020-08-13
FDA-cleared K201444

Syngo.via RT Image Suite

Siemens Medical Solutions USA, Inc.

syngo.via RT Image Suite VB50 supports trained radiation-oncology professionals with multimodality visualization, registration, contouring, simple treatment preparation, and DICOM export; this release expanded deep-learning automatic contouring.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2020-08-13
FDA-cleared K192437

Arterys MICA

Arterys Inc.

Authorized purpose: Support-tool image processing for quantitative cardiovascular assessment and oncologic lesion evaluation, quantification, follow-up, and documentation to aid trained healthcare professionals in diagnosis; the software does not directly generate a diagnosis or potential findings.

Modality
CT/CTA; MRI
Anatomy
Heart and major vessels for Cardio AI; oncology lesion anatomy is not further specified in the FDA statement.
Decision
2020-03-25
FDA-cleared K193281

Hepatic VCAR

GE Medical Systems SCS

Authorized purpose: Analysis and visualization of liver CT data from DICOM 3.0-compliant CT scans to assess liver morphology and lesion change over time and to process, review, archive, print, and distribute liver CT studies.

Modality
CT/CTA
Anatomy
Liver, liver lobes, liver segments, liver lesions, and hepatic artery
Decision
2020-03-20
FDA-cleared K193248

Biograph Vision, Biograph mCT Family of PET/CTs

Siemens Medical Solutions USA, Inc

Authorized purpose: The Biograph Vision and Biograph mCT family are combined PET/CT systems for acquiring, reconstructing, fusing, displaying, evaluating, and archiving PET and CT studies for trained nuclear-medicine and radiology professionals across labeled oncology, cardiology, neurology, and radiotherapy-planning workflows.

Modality
PET/SPECT/Nuclear Medicine
Anatomy
Multi-region
Decision
2020-02-14
FDA-cleared K192377

Ethos Treatment Management, Ethos Treatment Planning, Ethos Radiotherapy System, Halcyon

Varian Medical Systems, Inc.

Authorized purpose: Ethos Treatment Management is indicated for managing and monitoring radiation-therapy treatment plans and sessions. Ethos Treatment Planning is indicated for generating and modifying radiation-therapy treatment plans. The Halcyon and Ethos Radiotherapy System are indicated for delivery of stereotactic radiosurgery and precision radiotherapy for lesions, tumors, and conditions anywhere in the body where radiation is indicated for adults and pediatric patients.

Modality
Radiotherapy Planning Imaging
Anatomy
Lesions, tumors, and conditions anywhere in the body; radiation-treatment plans and sessions
Decision
2020-02-10
FDA-cleared K193109

MRCAT brain

Philips Medical Systems MR Finland

Generation of MR-derived attenuation information for photon radiotherapy planning of primary and metastatic brain tumors.

Modality
Radiotherapy Planning Imaging
Anatomy
Brain
Decision
2020-01-24
FDA-cleared K192065

Syngo.Via RT Image Suite

Siemens Medical Solutions USA, Inc.

syngo.via RT Image Suite VB40 supports trained radiation-oncology professionals with multimodality visualization, registration, contouring, simple treatment preparation, DICOM export, and optional MR-based Synthetic CT.

Modality
Radiotherapy Planning Imaging
Anatomy
Multi-region
Decision
2019-09-18
FDA-cleared K191384

RayCare 2.3

RaySearch Laboratories AB (publ)

Authorized purpose: RayCare is an oncology information system used to support workflows, scheduling, and clinical information management for oncology care and follow-up. It may transfer, store, convert, and display patient data in cancer care including radiation therapy, medical oncology, and surgical oncology. RayCare is not intended for diagnostic activities.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Patient data across radiation, medical, and surgical oncology care; no diagnostic anatomy
Decision
2019-07-08
FDA-cleared K190017

LiverMultiScan (LMSv3)

Perspectum Diagnostics Ltd

Authorized purpose: LiverMultiScan LMSv3 is MR diagnostic software for non-invasive liver evaluation from abdominal MR images, including automated liver segmentation and proton-density fat fraction, T2 star, and corrected T1 measurements.

Modality
MRI
Anatomy
Abdomen including liver
Decision
2019-06-27
FDA-cleared K173749

AMRA Profiler

AMRA Medical AB

Authorized purpose: AMRA Profiler is MR diagnostic software for non-invasive fat and muscle evaluation, including liver fat fraction, T2 star, and muscle volume measurements from supported DICOM MR datasets.

Modality
MRI
Anatomy
Body including liver and skeletal muscle
Decision
2018-12-06
FDA-cleared K182034

Arterys MICA

Arterys Inc.

Authorized purpose: DICOM/non-DICOM image and data management with optional quantitative cardiac MR and oncology lesion evaluation, quantification, follow-up, and documentation support; the software does not directly generate a diagnosis or potential findings.

Modality
CT/CTA; MRI
Anatomy
Heart and major vessels for the optional Cardio AI module; lung and liver lesions or nodules for the optional Oncology AI module; the base viewer handles broader radiological image data.
Decision
2018-10-17
FDA-cleared K173542

Arterys Oncology DL

Arterys Inc.

Authorized purpose: Oncology imaging workflow for viewing, manipulating, 3D visualizing, and comparing images and assessing/documenting morphological changes at diagnostic and therapy follow-up; supports lesion evaluation, quantification, follow-up, and documentation.

Modality
CT/CTA; MRI
Anatomy
Oncologic lesions, with semi-automated segmentation explicitly described for lung nodules and liver lesions.
Decision
2018-01-25
FDA-cleared K173420

Radiomics App v1.0

Microsoft Corp.

Authorized purpose: Microsoft Radiomics App v1.0 is a software-only medical device for trained radiation oncologists, dosimetrists, and physicists to derive organ and tumor contours for radiation-treatment planning. It supports CT and MR images, image and contour review, contour creation and modification, transfer to treatment-planning systems, adaptive-therapy support, archiving, tumor and healthy-structure localization, image fusion, and three-dimensional rendering. Images reviewed with the software should not be used for primary image interpretations, and it is not for digital mammography.

Modality
Radiotherapy Planning Imaging
Anatomy
CT and MR images; tumors and healthy anatomical structures for radiotherapy planning
Decision
2017-12-27
FDA-cleared K170747

syngo Application Software

Siemens Medical Solutions, USA, Inc.

Authorized purpose: syngo Application Software provides real-time viewing, image manipulation, 3D visualization, communication, and storage of medical images and data on exchange media for diagnostic viewing, post-processing, and viewing or post-processing during interventional procedures. It may run on a stand-alone workstation, send and receive DICOM data over a network, be deployed on Siemens angiography systems, and be combined with fluoroscopy or radiographic systems for image-guided surgery and interventional cardiology, electrophysiology, oncology, radiology, and neuroradiology.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Anatomy represented in supported medical images and interventional procedures
Decision
2017-06-09
FDA-cleared K160088

Cydar EV

Cydar Ltd.

Authorized purpose: Cydar EV provides image guidance by overlaying preoperative 3D vessel anatomy from a previously acquired contrast-enhanced diagnostic CT scan onto live fluoroscopic images to assist positioning guidewires, catheters, and other endovascular devices. It is intended for fluoroscopy-guided endovascular procedures in the lower thorax, abdomen, and pelvis, including AAA and mid-distal TAA repair, angioplasty, stenting, and embolization in specified iliac arteries and corresponding veins, and is not intended for liver, kidney, or pelvic-organ procedures.

Modality
Fluoroscopy/Angiography
Anatomy
Lower thorax, abdomen, and pelvis; iliac vessels and corresponding veins
Decision
2016-07-07
FDA-cleared K133649

HEPATIC VCAR

GE MEDICAL SYSTEMS SCS

Authorized purpose: Hepatic VCAR analyzes CT liver images to assess liver morphology and liver lesions with automated liver, lobe, segment, lesion, and measurement tools that a clinician can edit and confirm.

Modality
CT/CTA
Anatomy
Liver
Decision
2014-04-22